Gilead Sciences, Inc.
Modulators of toll-like receptors

Abstract:

Provided are modulators of TLRs of Formula II: ##STR00001## pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.